Atlas Trials

Pioglitazone vs. Placebo in Association With Pegylated Interferon and Ribavirin in HCV Patients With Insulin Resistance

Clinical trial NCT00927290 · TERMINATED

Trial details

NCT number
NCT00927290
Sponsor
French National Agency for Research on AIDS and Viral Hepatitis
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Hepatitis CInsulin Resistance
Start date
2009-12-03
Primary completion
2012-07-06
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.